• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Horizon Pharma Plc

+ Add to Watchlist

HZNP:US

12.3700 USD 0.0800 0.65%

As of 20:10:00 ET on 09/18/2014.

Trading has been halted for HZNP:US - Reason not available

Snapshot for Horizon Pharma Plc (HZNP)

Open: 12.3200 Day's Range: 12.0300 - 12.4900 Volume: 981,172
Previous Close: 12.2900 52wk Range: 3.0600 - 18.3000 1-Yr Rtn: +295.46%

Stock Chart for HZNP

No chart data available.
  • HZNP:US 12.3850
  • 1D
  • 1M
  • 1Y
12.2900
Interactive HZNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HZNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.5110
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0021
Est. EPS (USD) (12/2014) 0.6340
Est. PEG Ratio -
Market Cap (M USD) 924.90
Shares Outstanding (M) 74.77
30 Day Average Volume 1,501,962
Price/Book (mrq) 11.3910
Price/Sale (ttm) 4.8779
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HZNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HZNP

Horizon Pharma Plc is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.

Timothy P WalbertChairman/President/CEORobert J De VaereExec VP/CFO/Secretary
Paul W HoelscherExec VP:FinanceRobert F Carey "Bob"Exec VP/Chief Business Officer
More Company Profile & Key Executives for HZNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil